Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers.
Peng JiangJin HuangYing DengJing HuZhen HuangMingzhu JiaJiaojiao LongZhuoying HuPublished in: Cancer management and research (2020)
This nomogram model involving immunohistochemical markers can better predict recurrence in FIGO stages I-III EC.